Keywords :
Crohn’s disease; inflammatory bowel disease; murine models; therapeutics; ulcerative colitis; Trinitrobenzenesulfonic Acid; Dextran Sulfate; Animals; Chronic Disease; Dextran Sulfate/adverse effects; Disease Models, Animal; Humans; Mice; Trinitrobenzenesulfonic Acid/toxicity; Colitis/chemically induced; Inflammatory Bowel Diseases/chemically induced; Colitis; Inflammatory Bowel Diseases; Catalysis; Molecular Biology; Spectroscopy; Computer Science Applications; Physical and Theoretical Chemistry; Organic Chemistry; Inorganic Chemistry; General Medicine
Abstract :
[en] Crohn's disease (CD) and ulcerative colitis (UC) are both highly inflammatory diseases of the gastrointestinal tract, collectively known as inflammatory bowel disease (IBD). Although the cause of IBD is still unclear, several experimental IBD murine models have enabled researchers to make great inroads into understanding human IBD pathology. Here, we discuss the current pre-clinical experimental murine models for human IBD, including the chemical-induced trinitrobenzene sulfonic acid (TNBS) model, oxazolone and dextran sulphate sodium (DSS) models, the gene-deficient I-kappa-B kinase gamma (Iκκ-γ) and interleukin(IL)-10 models, and the CD4+ T-cell transfer model. We offer a comprehensive review of how these models have been used to dissect the etiopathogenesis of disease, alongside their limitations. Furthermore, the way in which this knowledge has led to the translation of experimental findings into novel clinical therapeutics is also discussed.
Funding text :
This research was funded by the EUROPEAN COMMISSION, grant number 65739, and the NATIONAL RESEARCH FOUNDATION, grant number 99074.
Scopus citations®
without self-citations
128